At 4.6% CAGR, Middle East & Africa Lithotripsy Market is Projected to be Worth US$ 82.58 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa lithotripsy market was valued at US$ 57.68 million in 2023 and is expected to reach US$ 82.58 million by 2031, registering a CAGR of 4.6% from 2023 to 2031. Launch of innovative lithotripsy devices and medical reimbursement/coverage for noninvasive lithotripsy procedure are among the critical factors attributed to drive the Middle East & Africa lithotripsy market growth.

Surgery is a traditional treatment option for patients suffering from kidney stones. These surgeries include nephrectomy and endoscopic treatment of the urethra. However, in the past few years, several new approaches have been developed such as noninvasive lithotripsy techniques for the treatment of upper urinary tract kidney stones. Patients are gradually shifting toward noninvasive procedures owing to increased awareness. Therefore, medical coverage/reimbursement for noninvasive lithotripsy procedures leads to an increase in patient visits to specialized lithotripsy centers and hospitals, which fuels the market growth.

On the contrary, rise in product recalls by FDA hampers the growth of Middle East & Africa lithotripsy market.

By product type, the Middle East & Africa lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices, intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held 60.6% share of Middle East & Africa lithotripsy market share in 2023, amassing US$ 34.93 million. It is projected to garner US$ 52.80 million by 2031 to register 5.3% CAGR during 2023-2031.

In term of application, the Middle East & Africa lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held 39.2% share of Middle East & Africa lithotripsy market share in 2023, amassing US$ 22.61 million. It is projected to garner US$ 34.58 million by 2031 to register 6.0% CAGR during 2023-2031.

Based on end user, the Middle East & Africa lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held 73.4% share of Middle East & Africa lithotripsy market share in 2023, amassing US$ 42.37 million. It is projected to garner US$ 62.83 million by 2031 to register 5.0% CAGR during 2023-2031.

Based on country, the Middle East & Africa lithotripsy market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 37.4% share of Middle East & Africa aircraft brackets market in 2023. It was assessed at US$ 21.57 million in 2023 and is likely to hit US$ 32.81 million by 2031, registering a CAGR of 5.4% during 2023-2031.

Key players operating in the Middle East & Africa lithotripsy market are Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical, among others.

• April-2024: Olympus announced RenaFlex single-use flexible ureteroscope system used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones. This new product works in collaboration with combination with the compatible "CV-S1 Video System" for flexible single-use endoscopes.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com